Patient Experience Data: US FDA Guidance Offers Other Ways To Share
Executive Summary
Beyond submitting proposed guidances to FDA, stakeholders may develop patient registries, conduct natural history studies, and establish partnerships to help advance patient-focused drug development, agency suggests.